ヒトインドレアミン2,3-ダイオキシゲナーゼ1における自殺抑制剤の結合経路のマッピング
1Department of Physiology and Biophysics , Albert Einstein College of Medicine , Bronx , New York 10461 , United States.
Journal of the American Chemical Society
|October 24, 2018
まとめ
この研究は,がんの免疫療法のためのヒトインドロアミン2,3-二酸化酵素1 (hIDO1) を標的とした新しい自殺抑制剤であるBMS-986205の完全な結合機構を明らかにした. 構造的な洞察が 高い効果と 独特の抑制を説明します
科学分野:
- 生物化学
- 構造生物学
- 薬物の発見
背景:
- ヒューマン・インドレアミン2,3-二酸化酵素1 (hIDO1) は,がん免疫療法における重要な標的である.
- BMS-986205はhIDO1の強力な自殺阻害剤ですが,そのメカニズムは不明です.
研究 の 目的:
- BMS-986205のhIDO1抑制の完全な結合機構と構造的基礎を解明する.
- hIDO1を標的とする新しいがん治療薬の開発のための洞察を提供すること.
主な方法:
- hIDO1-BMS複合体のX線結晶学
- 阻害剤結合経路と形状の変化の分析
主要な成果:
- hIDO1へのBMS-986205の完全な結合軌道を定義した.
- 活性部位の展開とヘム放出を含む,連続した形状の変化が検出され,阻害剤への結合につながった.
- 結合中に拡張された,曲げられた,そして曲げられた形状を採用する観察された阻害剤.
結論:
- 構造データは,BMS-986205の効能と自殺抑制の分子説明を提供する.
- 発見は,hIDO1および関連酵素のための新しい薬物開発戦略を示唆しています.
関連する概念動画
Orthogonal Trajectories
61
Orthogonal trajectories describe the geometric relationship between two families of curves that intersect each other at right angles. One illustrative case involves a family of parabolas that open sideways along the x-axis. These curves share a common shape but differ by a scaling parameter, resulting in a set of curves that all pass through the origin and widen at different rates.Determining Orthogonal TrajectoriesTo identify the orthogonal trajectories for these parabolas, the first step...
61
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
The Equilibrium Binding Constant and Binding Strength
15.1K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K
The Equilibrium Binding Constant and Binding Strength
10.0K
10.0K
Ligand Binding Sites
15.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.1K
Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K


